Reuters logo
BRIEF-Lannett announces approval for Lopinavir and Ritonavir oral solution USP, 80 mg/20 mg per ml
January 3, 2017 / 6:17 PM / a year ago

BRIEF-Lannett announces approval for Lopinavir and Ritonavir oral solution USP, 80 mg/20 mg per ml

Jan 3 (Reuters) - Lannett Company Inc :

* Lannett announces approval for Lopinavir And Ritonavir oral solution USP, 80 mg/20 mg per ml

* Anticipate launching Lopinavir and Ritonavir oral solution USP shortly Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +91 806 749 1136)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below